{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:57:50Z","timestamp":1790542670209,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e33145","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T23:49:51Z","timestamp":1718408991000},"page":"e33145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimization of preparation method and specificity verification of cat CD19 monoclonal antibody for disease diagnosis and treatment"],"prefix":"10.1016","volume":"10","author":[{"given":"Liya","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1886-0853","authenticated-orcid":false,"given":"Yongyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2024.e33145_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2162-3619-1-36","article-title":"CD19: a biomarker for B cell development, lymphoma diagnosis and therapy","volume":"1","author":"Wang","year":"2012","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33145_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2006.12.004","article-title":"B cell signaling and autoimmune diseases: CD19\/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity","volume":"46","author":"Fujimoto","year":"2007","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33145_bib3","first-page":"143","article-title":"Anti-CD19 monoclonal antibodies: a new approach to lymphoma therapy","volume":"4","author":"NaddafiF","year":"2015","journal-title":"Int J Mol Cell Med (Summer"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33145_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41467-019-13880-1","article-title":"Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy","volume":"11","author":"Sheih","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e33145_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0167-5699(94)90274-7","article-title":"The CD19\/CD21 signal transduction complex of B lymphocytes","volume":"15","author":"Tedder","year":"1994","journal-title":"Immunol. Today"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33145_bib6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jaci.2013.01.046","article-title":"B-cell biology and development","volume":"131","author":"Pieper","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33145_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00432-021-03833-x","article-title":"Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma","volume":"148","author":"Zinzani","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33145_bib8","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/annonc\/mdy092","article-title":"Antibody therapy targeting CD19 for B-cell non-Hodgkin's lymphoma","volume":"29","author":"Makita","year":"2018","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e33145_bib9","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.4049\/jimmunol.157.10.4371","article-title":"CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity","volume":"157","author":"Sato","year":"1996","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e33145_bib10","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.4049\/jimmunol.159.7.3278","article-title":"Regulation of B lymphocyte development and activation by the CD19\/CD21\/CD81\/Leu 13 complex requires the cytoplasmic domain of CD19","volume":"159","author":"Sato","year":"1997","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33145_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-019-0819-1","article-title":"CAR-T \"the living drugs\", immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33145_bib12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/07853890.2022.2031272","article-title":"Comparison of the deep immune profiling of B cell subsets between healthy adults and Sjogren's syndrome","volume":"54","author":"Feng","year":"2022","journal-title":"Ann. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e33145_bib13","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1038\/s41375-021-01281-7","article-title":"Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia","volume":"35","author":"Dourthe","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.heliyon.2024.e33145_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2021.105931","article-title":"Expression of soluble recombinant human matrix metalloproteinase 9 and generation of its monoclonal antibody","volume":"187","author":"Jeong","year":"2021","journal-title":"Protein Expr. Purif."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33145_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.xphs.2019.05.031","article-title":"Considerations for the design of antibody-based therapeutics","volume":"109","author":"Goulet","year":"2020","journal-title":"J. Pharmaceut. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33145_bib16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1631\/jzus.BQICC711","article-title":"Advances in monoclonal antibody application in myocarditis","volume":"14","author":"Han","year":"2013","journal-title":"J. Zhejiang Univ. - Sci. B"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33145_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/15321819.2018.1515775","article-title":"A brief review of monoclonal antibody technology and its representative applications in immunoassays","volume":"39","author":"Gao","year":"2018","journal-title":"J. Immunoassay Immunochem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33145_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000084184","article-title":"Minimizing the immunogenicity of antibodies for clinical application","volume":"26","author":"Gonzales","year":"2005","journal-title":"Tumour Biol"},{"issue":"Pt B","key":"10.1016\/j.heliyon.2024.e33145_bib19","article-title":"Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition","volume":"113","author":"Yuti","year":"2022","journal-title":"Int. Immunopharm."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e33145_bib20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa1609783","article-title":"Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia","volume":"376","author":"Kantarjian","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33145_bib21","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33145_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2273","article-title":"Translation of new cancer treatments from pet dogs to humans","volume":"8","author":"Paoloni","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33145_bib23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1354\/vp.42-6-805","article-title":"Aberrant p53 expression in feline vaccine-associated sarcomas and correlation with prognosis","volume":"42","author":"Hershey","year":"2005","journal-title":"Vet. Pathol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33145_bib24","article-title":"Immunometric double-antibody sandwich enzyme-linked immunosorbent assay","volume":"2017","author":"Kohl","year":"2017","journal-title":"Cold Spring Harb. Protoc."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e33145_bib25","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14712598.2013.822065","article-title":"Potential therapeutic roles for antibody mixtures","volume":"13","author":"Raju","year":"2013","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.heliyon.2024.e33145_bib26","series-title":"Preparation and Identification of the Monoclonal Antibody against Four Canine B Cell Surface Markers","author":"Du","year":"2022"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33145_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0923-1811(99)00043-2","article-title":"CD19 is a central response regulator of B lymphocyte signaling thresholds governing autoimmunity","volume":"22","author":"Sato","year":"1999","journal-title":"J. Dermatol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33145_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.leukres.2007.07.002","article-title":"Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines","volume":"32","author":"Stanciu-Herrera","year":"2008","journal-title":"Leuk. Res."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e33145_bib29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0014-5793(99)00713-9","article-title":"Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding","volume":"453","author":"Le Gall","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.heliyon.2024.e33145_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40425-016-0200-7","article-title":"Canine cancer immunotherapy studies: linking mouse and human","volume":"4","author":"Park","year":"2016","journal-title":"Journal for immunotherapy of cancer"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33145_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/ilar\/ily014","article-title":"Of mice, dogs, pigs, and men: choosing the appropriate model for immuno-oncology research","volume":"59","author":"Overgaard","year":"2018","journal-title":"ILAR J."},{"issue":"5\u20136","key":"10.1016\/j.heliyon.2024.e33145_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/10428199509059636","article-title":"CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy","volume":"18","author":"Scheuermann","year":"1995","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33145_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12896-022-00761-7","article-title":"Preparation of a novel monoclonal antibody against active components of PHA-L from Phaseolus vulgaris and its functional characteristics","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Biotechnol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33145_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032052","article-title":"Preparation of mouse monoclonal antibody for RB1CC1 and its clinical application","volume":"7","author":"Hama","year":"2012","journal-title":"PLoS One"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402409176X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402409176X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:51:43Z","timestamp":1790542303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402409176X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S240584402409176X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33145","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of preparation method and specificity verification of cat CD19 monoclonal antibody for disease diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e33145"}}